U.S. drugmaker Merck & Co, already one of the leaders in the hot area of cancer immunotherapy, said on Wednesday it had agreed to buy Viralytics for 502 million Australian dollars ($394 million) to expand its...
Brinton pharma in talks with VCs to raise up to Rs 150 crore
Tata Capital Healthcare Fund-backed Brinton Pharma is looking to raise Rs 120-150 crore in a follow on round and is in talks with venture capital funds to raise cash that would primarily be used to expand the company’s...
Aurobindo Pharma eyes European business of Apotex
Aurobindo Pharma has expressed early stage interest in the European business of the $1.7-billion privately held Canadian drugmaker Apotex. Known for its high profile litigations in the US against MNC pharma players...
Malvinder, Shivinder Singh move Supreme Court to challenge High Court ruling in favour of Daiichi Sankyo
Former RanbaxyBSE 5.63 % promoters Malvinder and Shivinder Singh have approached the Supreme Court seeking permission to appeal a high court judgement allowing Daiichi Sankyo to recover about Rs 3,500 crore from them as...
Glaxo, Reckitt are said only bidders for Pfizer’s consumer unit
GlaxoSmithKline Plc and Reckitt Benckiser Group Plc are the only companies to have submitted non-binding bids for Pfizer Inc.’s consumer business after rival candidates walked away, according to people familiar with the...
Sanofi beats Novo to buy Ablynx for $4.8 billion in biotech M&A boom
French drugmaker Sanofi has agreed to buy Belgian biotech company Ablynx for 3.9 billion euros ($4.8 billion), beating Novo Nordisk and marking its second big deal this month after buying Bioverativ. The transaction is...
Biotech M&A takes off as Sanofi and Celgene spend $20 billion
Biotech deal activity exploded on Monday with French drugmaker Sanofi and U.S.-based Celgene spending a combined total of more than $20 billion to add new products for haemophilia and cancer to their medicine cabinets...
Carlyle Group leads race for 15 per cent in Mankind Pharmaceuticals
Carlyle Group is leading the race to invest as much as $500 million for a 15% stake in Mankind Pharmaceuticals in what could become one of the largest private equity transactions in the pharma space. The transaction, if...
Torrent Pharma buys US firm Bio-Pharm
Torrent PharmaceuticalsBSE 0.36 % has acquired Bio-Pharm, a generic and over-the-counter drugmaker based in Levittown, Pennsylvania, for an undisclosed sum. “This acquisition is an important step for increasing...
Ipca Laboratories acquires US-based API developer Pisgah Labs for $9.65 mn
Ipca Laboratories today said its two subsidiaries have fully acquired US-based Pisgah Labs Inc for $9.65 million. In a BSE filing Ipca Laboratories announced “acquisition of 100 percent share capital of Pisgah...
Pharma M&A: buying its way back to growth
Why Indian pharmaceutical companies are keen on global acquisitions is not hard to fathom. A Crisil report estimates the sector’s revenue to increase by 9% per annum till fiscal 2020, with overseas revenue growing by a...
Hilleman Labs to partner future vaccine manufacturing hub
Hilleman Laboratories, a joint- venture between pharma major MSD and Wellcome Trust, today said it has partnered a new future vaccine manufacturing hub led by Imperial College, London. UK Department for Health has...
